DNA mismatch repair and acquired cisplatin resistance in E. coli and human ovarian carcinoma cells
- 18 October 2002
- journal article
- Published by Elsevier in DNA Repair
- Vol. 2 (1) , 73-89
- https://doi.org/10.1016/s1568-7864(02)00187-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Converting a DNA damage checkpoint effector (UmuD2C) into a lesion bypass polymerase (UmuD'2C)The EMBO Journal, 2001
- DNA MISMATCH REPAIR AND GENETIC INSTABILITYAnnual Review of Genetics, 2000
- Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cellsOncogene, 2000
- Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repairThe EMBO Journal, 2000
- A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancerOncogene, 1999
- MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomasOncogene, 1998
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal Of Cancer, 1998
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- Mutations of GTBP in Genetically Unstable CellsScience, 1995
- Mismatch correction at O6-methylguanine residues in E. coli DNANature, 1982